Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4FYH

Crystal structure of rcl with phospho-triciribine

Summary for 4FYH
Entry DOI10.2210/pdb4fyh/pdb
Related2KLH 4FYI 4FYK
DescriptorDeoxyribonucleoside 5'-monophosphate N-glycosidase, 5-methyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,8-pentaazaacenaphthylen-3-amine, SULFATE ION, ... (4 entities in total)
Functional Keywordsdeoxyribonucleoside 5'-monophosphate n-glycosidase, hydrolase-inhibitor complex, hydrolase/inhibitor
Biological sourceRattus norvegicus (brown rat,rat,rats)
Cellular locationCytoplasm (By similarity): O35820
Total number of polymer chains4
Total formula weight70774.79
Authors
Labesse, G.,Padilla, A.,Kaminski, P.A. (deposition date: 2012-07-04, release date: 2013-01-02, Last modification date: 2024-02-28)
Primary citationPadilla, A.,Amiable, C.,Pochet, S.,Kaminski, P.A.,Labesse, G.
Structure of the oncoprotein Rcl bound to three nucleotide analogues.
Acta Crystallogr.,Sect.D, 69:247-255, 2013
Cited by
PubMed Abstract: Rcl is a novel N-glycoside hydrolase found in mammals that shows specificity for the hydrolysis of 5'-monophosphate nucleotides. Its role in nucleotide catabolism and the resulting production of 2-deoxyribose 5-phosphate has suggested that it might fuel cancer growth. Its expression is regulated by c-Myc, but its role as an oncoprotein remains to be clarified. In parallel, various nucleosides have been shown to acquire pro-apoptotic properties upon 5'-monophosphorylation in cells. These include triciribine, a tricyclic nucleoside analogue that is currently in clinical trials in combination with a farnesyltransferase inhibitor. Similarly, an N(6)-alkyl-AMP has been shown to be cytotoxic. Interestingly, Rcl has been shown to be inhibited by such compounds in vitro. In order to gain better insight into the precise ligand-recognition determinants, the crystallization of Rcl with these nucleotide analogues was attempted. The first crystal structure of Rcl was solved by molecular replacement using its NMR structure in combination with distantly related crystal structures. The structures of Rcl bound to two other nucleotides were then solved by molecular replacement using the previous crystal structure as a template. The resulting structures, solved at high resolution, led to a clear characterization of the protein-ligand interactions that will guide further rational drug design.
PubMed: 23385460
DOI: 10.1107/S0907444912045039
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.44 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon